William Grossman's Insider Trades & SAST Disclosures
William Grossman's most recent trade in Day One Biopharmaceuticals Inc was a trade of 32,335 Stock Option (right to buy Common Stock) done . Disclosure was reported to the exchange on May 23, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William Grossman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals... | William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Day One Biopharmaceuticals... | Grossman William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.68 per share. | 16 Jun 2021 | 3,891 | 20,723 (0%) | 0% | 23.7 | 92,139 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.13 per share. | 16 Jun 2021 | 3,047 | 24,741 (0%) | 0% | 24.1 | 73,524 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.77 per share. | 16 Jun 2021 | 127 | 24,614 (0%) | 0% | 24.8 | 3,146 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.37 per share. | 23 Apr 2021 | 4,133 | 6,717 (0%) | 0% | 31.4 | 129,652 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.03 per share. | 16 Mar 2021 | 2,127 | 10,850 (0%) | 0% | 35.0 | 74,509 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 112,500 | 112,500 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 18,750 | 25,477 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 31.35 per share. | 16 Dec 2020 | 2,117 | 6,727 (0%) | 0% | 31.4 | 66,368 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2020 | 100,000 | 100,600 (0%) | 0% | 0 | Common Stock | |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 19.77 per share. | 31 Jul 2020 | 100 | 500 (0%) | 0% | 19.8 | 1,977 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 19.68 per share. | 31 Jul 2020 | 100 | 600 (0%) | 0% | 19.7 | 1,968 | Common Stock |
| Arcus Biosciences Inc | William Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 55,000 | 55,400 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges